pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2013-0-6-92-98pulmo-315Research ArticleОБЗОРЫREVIEWРанние и поздние легочные осложнения лучевой терапии лимфомы ХоджкинаEarly and long-term pulmonary complications of radiotherapy of Hodgkin's lymphomaДаниленкоА. А.DanilenkoA. A.

к. м. н., старший научный сотрудник отделения лучевой и лекарственной терапии гемобластозов

249036, Калужская обл., Обнинск, ул. Королева, 4. Тел.: 8-909-250-02-22.

danilenko@mrrc.obninsk.ruШахтаринаС. В.ShakhtarinaS. V.

д. м. н., ведущий научный сотрудник отделения лучевой и лекарственной терапии гемобластозов 

249036, Калужская обл., Обнинск, ул. Королева, 4. Тел.: (48439) 9-31-01.

danilenko@mrrc.obninsk.ruФГБУ "Медицинский радиологический научный центр" Минздрава РоссииRussian Federation201328122013069298Copyright © Даниленко А.А., Шахтарина С.В., 20132013Даниленко А.А., Шахтарина С.В.Danilenko A.A., Shakhtarina S.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/315

Ранние и поздние легочные осложнения лучевой терапии лимфомы Ходжкина

Early and long-term pulmonary complications of radiotherapy of Hodgkin's lymphoma.

лимфома Ходжкиналучевые повреждения легкихпневмонитпневмофиброзHodgkin's lymphomalung radiation injurypneumonitispulmonary fibrosisReferencesWilliams J.P., Johnston C.J., Finkelstein J.N. Treatment for radiation-induced pulmonary late effects: Spoiled for choice or looking in the wrong direction? Curr. Drug Targets 2010; 11 (11): 1386–1394.Williams J.P., Johnston C.J., Finkelstein J.N. Treatment for radiation-induced pulmonary late effects: Spoiled for choice or looking in the wrong direction? Curr. Drug Targets 2010; 11 (11): 1386–1394.Notter R.H., Finkelstein J.N., Holm B.A. Lung injury: mechanisms, pathophysiology, and therapy. New York: Taylor Fransis, 2005.Notter R.H., Finkelstein J.N., Holm B.A. Lung injury: mechanisms, pathophysiology, and therapy. New York: Taylor Fransis, 2005.Bentzen S.M. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nature Rev. Cancer. 2006; 6: 702–713.Bentzen S.M. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nature Rev. Cancer. 2006; 6: 702–713.Mikkelsen R.B., Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003; 22: 5734–5754.Mikkelsen R.B., Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003; 22: 5734–5754.Fleckenstein K., Zgonjanin L., Chen L. et al. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2007; 68: 196–204.Fleckenstein K., Zgonjanin L., Chen L. et al. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2007; 68: 196–204.Ghafoori P., Marks L.B., Vujaskovic Z. et al. Radiationinduced lung injury: assessment, management, and prevention. Oncology 2008; 22 (1): 37–47.Ghafoori P., Marks L.B., Vujaskovic Z. et al. Radiationinduced lung injury: assessment, management, and prevention. Oncology 2008; 22 (1): 37–47.Young B., Lowe J.S., Stevens A., Heath J.W. Wheather′s functional histology: a text and colour atlas. 5rd ed. London: Churchill Livingstone, 2006.Young B., Lowe J.S., Stevens A., Heath J.W. Wheather′s functional histology: a text and colour atlas. 5rd ed. London: Churchill Livingstone, 2006.Rubin P., Shapiro D.L., Finklestein J.N. et al. The early release of surfactant following lung irradiation of alveolar type II cells. Int. J. Radiat. Oncol. Biol. Phys.1980; 6: 75–77.Rubin P., Shapiro D.L., Finklestein J.N. et al. The early release of surfactant following lung irradiation of alveolar type II cells. Int. J. Radiat. Oncol. Biol. Phys.1980; 6: 75–77.Allavena C., Conroy T., Aletti P. et al. Late cardiopulmonary toxicity after treatment for Hodgkin′s disease. Br. J. Cancer 1992; 65: 908–912.Allavena C., Conroy T., Aletti P. et al. Late cardiopulmonary toxicity after treatment for Hodgkin′s disease. Br. J. Cancer 1992; 65: 908–912.Torrisi J.M., Schwartz L.H., Gollub M.J. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 2011; 258 (1): 41–56.Torrisi J.M., Schwartz L.H., Gollub M.J. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 2011; 258 (1): 41–56.Трахтенберг А.Х., Чиссов В.И. Клиническая онкопульмонология. М.: ГЭОТАР Медицина, 2000.Трахтенберг А.Х., Чиссов В.И. Клиническая онкопульмонология. М.: ГЭОТАР Медицина, 2000.Marks L.B., Fan M., Clough R. et al. Radiation-induced pulmonary injury: Symptomatic versus subclinical endpoints. Int. J. Radiat. Biol. 2000; 76: 469–475.Marks L.B., Fan M., Clough R. et al. Radiation-induced pulmonary injury: Symptomatic versus subclinical endpoints. Int. J. Radiat. Biol. 2000; 76: 469–475.Goethals I., Dierckx R., Meerleer G. et al. The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage. J. Nucl. Med. 2003; 44 (9): 1531–1539.Goethals I., Dierckx R., Meerleer G. et al. The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage. J. Nucl. Med. 2003; 44 (9): 1531–1539.Bria W.F., Kanarek D.J., Kazemi H. Prediction of postoperative pulmonary function following thoracic operations: value of ventilation-perfusion scanning. J. Thorac. Cardiovasc. Surg.1983; 86: 186–192.Bria W.F., Kanarek D.J., Kazemi H. Prediction of postoperative pulmonary function following thoracic operations: value of ventilation-perfusion scanning. J. Thorac. Cardiovasc. Surg.1983; 86: 186–192.Rubenstein J., Richter M., Moldofsky P. et al. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int. J. Radiat. Oncol. Biol. Phys.1988; 15: 83–87.Rubenstein J., Richter M., Moldofsky P. et al. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int. J. Radiat. Oncol. Biol. Phys.1988; 15: 83–87.Choi N., Kanarek D., Grillo H. Effect of post-operative radiotherapy on changes in pulmonary function in patients with stage II and IIIa lung carcinoma. Int. J. Radiat. Oncol. Biol. Phys.1990; 18: 95–99.Choi N., Kanarek D., Grillo H. Effect of post-operative radiotherapy on changes in pulmonary function in patients with stage II and IIIa lung carcinoma. Int. J. Radiat. Oncol. Biol. Phys.1990; 18: 95–99.Curran W., Moldofsky P., Solin L. Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int. J. Radiat. Oncol. Biol. Phys.1992; 24: 31–36.Curran W., Moldofsky P., Solin L. Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int. J. Radiat. Oncol. Biol. Phys.1992; 24: 31–36.Boersma L., Damen.E., de Boer R. et al. A new method to determine dose-effect relations for local lung function changes using correlated SPECT and CT data. Radiother. Oncol.1993; 29: 110–116.Boersma L., Damen.E., de Boer R. et al. A new method to determine dose-effect relations for local lung function changes using correlated SPECT and CT data. Radiother. Oncol.1993; 29: 110–116.Boersma L., Damen E., de Boer R.W. et al. Estimation of overall pulmonary function after irradiation using doseeffect relations for local functional injury. Radiother. Oncol. 1995; 36: 15–23.Boersma L., Damen E., de Boer R.W. et al. Estimation of overall pulmonary function after irradiation using doseeffect relations for local functional injury. Radiother. Oncol. 1995; 36: 15–23.Boersma L., Damen E., de Boer R.W. et al. Recovery of overall and local function loss 18 monthsafter irradiation for malignant lymphoma. J. Clin. Oncol.1996; 14: 1431–1441.Boersma L., Damen E., de Boer R.W. et al. Recovery of overall and local function loss 18 monthsafter irradiation for malignant lymphoma. J. Clin. Oncol.1996; 14: 1431–1441.Theuws J., Kwa S., Wagenaar A. et al. Prediction of overall pulmonary function loss in relation to 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother. Oncol. 1998; 49: 233–243.Theuws J., Kwa S., Wagenaar A. et al. Prediction of overall pulmonary function loss in relation to 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother. Oncol. 1998; 49: 233–243.Robnett T.J., Machtay M., Vines E.P. et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int. J. Radiat. Oncol. Biol. Phys.2000; 48: 89–94.Robnett T.J., Machtay M., Vines E.P. et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int. J. Radiat. Oncol. Biol. Phys.2000; 48: 89–94.Kim T.H., Cho K.H., Pyo H.R. et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimentional conformal radiation therapy for lung cancer. Radiology 2005; 235: 208–215.Kim T.H., Cho K.H., Pyo H.R. et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimentional conformal radiation therapy for lung cancer. Radiology 2005; 235: 208–215.Kong F.M., Haymann J.A., Griffith K.A. et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 1075–1086.Kong F.M., Haymann J.A., Griffith K.A. et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 1075–1086.Hua C., Hoth K.A., Wu S. et al. Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2012; 78 (1): 43–149.Hua C., Hoth K.A., Wu S. et al. Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2012; 78 (1): 43–149.Fox A.M., Dosoretz A.P., Mauch P.M. et al. Predictive factors for radiation pneumonitis in Hodgkin is lymphoma patients receiving combined modality therapy. Int. J. Radiat. Oncol. Biol. Phys. 2012; 83 (1): 277–283.Fox A.M., Dosoretz A.P., Mauch P.M. et al. Predictive factors for radiation pneumonitis in Hodgkin is lymphoma patients receiving combined modality therapy. Int. J. Radiat. Oncol. Biol. Phys. 2012; 83 (1): 277–283.Koh E.S., Sun A., Tran T.H. et al. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin′s lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 2006; 66 (1): 223–228.Koh E.S., Sun A., Tran T.H. et al. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin′s lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 2006; 66 (1): 223–228.Meadors M., Floyd J., Perry M.C. Pulmonary toxicity of chemotherapy. Semin. Oncol. 2006; 33: 98–105.Meadors M., Floyd J., Perry M.C. Pulmonary toxicity of chemotherapy. Semin. Oncol. 2006; 33: 98–105.Байсоголов Г.Д., Афанасова Н.В., Шахтарина С.В. и др. Изменения в легких у больных лимфогранулематозом I–II клинической стадии после комбинированного лечения. Мед. радиол. 1985; 3: 18–22.Байсоголов Г.Д., Афанасова Н.В., Шахтарина С.В. и др. Изменения в легких у больных лимфогранулематозом I–II клинической стадии после комбинированного лечения. Мед. радиол. 1985; 3: 18–22.Hirsch A., Van der Els N., Straus D.J. et al. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin`s disease. J. Clin. Oncol. 1996; 14: 1297–1305.Hirsch A., Van der Els N., Straus D.J. et al. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin`s disease. J. Clin. Oncol. 1996; 14: 1297–1305.Macann A., Bredenfeld H., Muller R.P. et al. Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin′s lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin′s Lymphoma Study Group. Int. J. Radiat. Oncol. Biol. Phys. 2008; 70 (1): 161–165.Macann A., Bredenfeld H., Muller R.P. et al. Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin′s lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin′s Lymphoma Study Group. Int. J. Radiat. Oncol. Biol. Phys. 2008; 70 (1): 161–165.Бардычев М.С., Цыб А.Ф. Местные лучевые повреждения. М.: Медицина, 1985.Бардычев М.С., Цыб А.Ф. Местные лучевые повреждения. М.: Медицина, 1985.Park K.J., Chung J.Y., Chun M.S. et al. Radiation-induced lung disease and the impact of radiation methods on imaging features. Radiographics 2000; 20 (1): 83–98.Park K.J., Chung J.Y., Chun M.S. et al. Radiation-induced lung disease and the impact of radiation methods on imaging features. Radiographics 2000; 20 (1): 83–98.Abratt R., Morgan G. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002; 35: 103–109.Abratt R., Morgan G. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002; 35: 103–109.Rubin P., Finkelstein J., Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 1992; 24: 93–101.Rubin P., Finkelstein J., Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 1992; 24: 93–101.Коврыжкина Т.А., Ильин Н.В., Акимов А.А. и др. Использование линейно-квадратичной модели для оценки поздних лучевых повреждений легких у больных лимфогранулематозом. Мед. радиол. 1997; 3: 59–63.Коврыжкина Т.А., Ильин Н.В., Акимов А.А. и др. Использование линейно-квадратичной модели для оценки поздних лучевых повреждений легких у больных лимфогранулематозом. Мед. радиол. 1997; 3: 59–63.Villani F., Busia A., Villani M. et al. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin′s disease. Anticancer Res. 2009; 29 (2): 777–784.Villani F., Busia A., Villani M. et al. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin′s disease. Anticancer Res. 2009; 29 (2): 777–784.Lund M.B., Kongerud J., Boe J. et al. Late complications after treatment of Hodgkin`s disease. Tidsskr. Norske Laegeforen. 1999; 119 (7): 933–937.Lund M.B., Kongerud J., Boe J. et al. Late complications after treatment of Hodgkin`s disease. Tidsskr. Norske Laegeforen. 1999; 119 (7): 933–937.Enrichi R.M., Anselmo A.P., Donato V. et al. Relapse and late complications in early-stage Hodgkin′s disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD. Haematologica 1999; 84 (10): 17–23.Enrichi R.M., Anselmo A.P., Donato V. et al. Relapse and late complications in early-stage Hodgkin′s disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD. Haematologica 1999; 84 (10): 17–23.Brusamolino E., Baio A., Orlandi E. et al. Long-term events in adult patients with clinical stage IA–IIA nonbulky Hodgkin`s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clin. Cancer Res. 2006; 12 (21): 6487–6493.Brusamolino E., Baio A., Orlandi E. et al. Long-term events in adult patients with clinical stage IA–IIA nonbulky Hodgkin`s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clin. Cancer Res. 2006; 12 (21): 6487–6493.Andrieu J.M., Jais J.P., Colonna P. et al. Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin′s disease at advanced stages. Ann. Oncol. 1998; 9 (2): 195–203.Andrieu J.M., Jais J.P., Colonna P. et al. Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin′s disease at advanced stages. Ann. Oncol. 1998; 9 (2): 195–203.Даниленко А.А., Шахтарина С.В., Афанасова Н.В., Павлов В.В. Изменения в легких у больных лимфомой Ходжкина после химиотерапии по схемам СОРР, ABVD, BEACOPP и облучения средостения в суммарной очаговой дозе 20–30 Гр. Клин. онкогематол. 2010; 3 (4): 354–358.Даниленко А.А., Шахтарина С.В., Афанасова Н.В., Павлов В.В. Изменения в легких у больных лимфомой Ходжкина после химиотерапии по схемам СОРР, ABVD, BEACOPP и облучения средостения в суммарной очаговой дозе 20–30 Гр. Клин. онкогематол. 2010; 3 (4): 354–358.Sasse A.D., Clark L.G., Sasse E.C., Clark O.A. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 2006; 64: 784–791.Sasse A.D., Clark L.G., Sasse E.C., Clark O.A. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 2006; 64: 784–791.Levi M., Knol J.A., Ensminger W.D. et al. Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys. Drug Metabol. Disposit. 2002; 30: 1425–1430.Levi M., Knol J.A., Ensminger W.D. et al. Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys. Drug Metabol. Disposit. 2002; 30: 1425–1430.Greenberg J.S., Epperly M.W. Antioxidant gene therapeutic approaches to normal tissue protection and tumor radiosensitization. In Vitro 2007; 21: 141–146.Greenberg J.S., Epperly M.W. Antioxidant gene therapeutic approaches to normal tissue protection and tumor radiosensitization. In Vitro 2007; 21: 141–146.Gauter7Fleckenstein B., Fleckenstein K., Owzar K. et al. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. Free Radic. Biol. Med. 2008; 44: 982–989.Gauter7Fleckenstein B., Fleckenstein K., Owzar K. et al. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. Free Radic. Biol. Med. 2008; 44: 982–989.Williams J.P., Hernady E., Johnston C.J. et al. Effect of administration of lovastatin on the development of late pulmonary effects following whole lung irradiation in a murine model. Radiat. Res. 2004; 161: 560–567.Williams J.P., Hernady E., Johnston C.J. et al. Effect of administration of lovastatin on the development of late pulmonary effects following whole lung irradiation in a murine model. Radiat. Res. 2004; 161: 560–567.Xie C.H., Zhang M.S., Zhou Y.F. et al. Chinese medicine Angelica sinensis supresses radiation-induced expression of TNF-α and TGF-β in mice. Oncol. Rep. 2006; 15: 1429–1436.Xie C.H., Zhang M.S., Zhou Y.F. et al. Chinese medicine Angelica sinensis supresses radiation-induced expression of TNF-α and TGF-β in mice. Oncol. Rep. 2006; 15: 1429–1436.Kozaka Y., Mitsumori M., Araki N. et al. Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast. Int. J. Clin. Oncol. 2006; 11: 482–486.Kozaka Y., Mitsumori M., Araki N. et al. Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast. Int. J. Clin. Oncol. 2006; 11: 482–486.

The authors declare that there are no conflicts of interest present.